• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

对《MiR-612通过HADHA介导的脂质重编程调节肝细胞癌的侵袭伪足》的更正

Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming.

作者信息

Liu Yang, Lu Li-Li, Wen Duo, Liu Dong-Li, Dong Li-Li, Gao Dong-Mei, Bian Xin-Yu, Zhou Jian, Fan Jia, Wu Wei-Zhong

机构信息

Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.

Department of Oral Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

出版信息

J Hematol Oncol. 2020 May 4;13(1):44. doi: 10.1186/s13045-020-00875-5.

DOI:10.1186/s13045-020-00875-5
PMID:32366313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7199356/
Abstract

An amendment to this paper has been published and can be accessed via the original article.

摘要

本文的一个修订版本已发表，可通过原始文章获取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c0/7199356/c87e4fa31798/13045_2020_875_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c0/7199356/c87e4fa31798/13045_2020_875_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89c0/7199356/c87e4fa31798/13045_2020_875_Fig1_HTML.jpg

相似文献

1
Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming.对《MiR-612通过HADHA介导的脂质重编程调节肝细胞癌的侵袭伪足》的更正
J Hematol Oncol. 2020 May 4;13(1):44. doi: 10.1186/s13045-020-00875-5.
2
Correction to: miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3.对《miR-3928v由HBx通过NF-κB/EGR1诱导并通过下调VDAC3促进肝细胞癌恶性进展》的更正
J Exp Clin Cancer Res. 2020 Aug 21;39(1):165. doi: 10.1186/s13046-020-01655-2.
3
Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo.miR-107对线粒体β-氧化的抑制作用会促进肝脏脂质积累并损害体内葡萄糖耐量。
Int J Obes (Lond). 2016 May;40(5):861-9. doi: 10.1038/ijo.2015.225. Epub 2015 Oct 26.
4
Author Correction: TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes.作者更正：TFPa/HADHA 是人类心肌细胞中脂肪酸β-氧化和心磷脂重塑所必需的。
Nat Commun. 2020 May 8;11(1):2387. doi: 10.1038/s41467-020-16186-9.
5
Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.对《YTHDF2缺失促进肝细胞癌炎症和血管异常化》一文的更正
Mol Cancer. 2020 Sep 4;19(1):137. doi: 10.1186/s12943-020-01257-8.
6
Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma.对《综合分析揭示肝细胞癌中的关键糖酵解调节因子》的更正
Cell Commun Signal. 2020 Oct 22;18(1):165. doi: 10.1186/s12964-020-00674-y.
7
Correction to: CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.对《CD103阳性癌症干细胞外泌体促进透明细胞肾细胞癌的上皮-间质转化：远距离MiR-19b-3p的作用》的更正
Mol Cancer. 2020 Sep 24;19(1):144. doi: 10.1186/s12943-020-01261-y.
8
Correction: miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer.更正：miR-27a是结直肠癌代谢重编程和化疗耐药性的主要调节因子。
Br J Cancer. 2020 May;122(10):1576. doi: 10.1038/s41416-020-0855-1.
9
Correction to: Overexpression of SOX4 induces up-regulation of miR-126 and miR-195 in LNCaP prostate cancer cell line.对《SOX4过表达诱导LNCaP前列腺癌细胞系中miR-126和miR-195上调》的更正
Cytotechnology. 2020 Aug;72(4):603. doi: 10.1007/s10616-020-00410-x.
10
Author Correction: Maternal vitamin C regulates reprogramming of DNA methylation and germline development.作者更正：母体维生素C调节DNA甲基化重编程和生殖系发育。
Nature. 2019 Dec;576(7785):E1. doi: 10.1038/s41586-019-1699-9.

引用本文的文献

1
MicroRNAs in Hepatocellular Carcinoma: Insights into Regulatory Mechanisms, Clinical Significance, and Therapeutic Potential.肝细胞癌中的微小RNA：对调控机制、临床意义及治疗潜力的见解
Cancer Manag Res. 2024 Oct 19;16:1491-1507. doi: 10.2147/CMAR.S477698. eCollection 2024.
2
Dietary stilbenes as modulators of specific miRNAs in prostate cancer.作为前列腺癌中特定微小RNA调节剂的膳食芪类化合物。
Front Pharmacol. 2022 Aug 24;13:970280. doi: 10.3389/fphar.2022.970280. eCollection 2022.
3
Eight Differential miRNAs in DN Identified by Microarray Analysis as Novel Biomarkers.

本文引用的文献

1
MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming.miR-612 通过 HADHA 介导的脂质重编程调节肝癌侵袭伪足。
J Hematol Oncol. 2020 Feb 7;13(1):12. doi: 10.1186/s13045-019-0841-3.
通过微阵列分析鉴定出的8种在糖尿病肾病中具有差异的微小RNA作为新型生物标志物
Diabetes Metab Syndr Obes. 2022 Mar 24;15:907-920. doi: 10.2147/DMSO.S355783. eCollection 2022.